BMP-2 Polymorphism c.893T>A (rs235768) Does Not Affect Bone Mineral Density in Female Population of Lahore

نویسندگان

  • Raazia Tasadduq
  • Bibi Nazia Murtaza
  • Asia Bibi
  • Abdul Rauf Shakoori
چکیده

Osteoporosis is systemic skeletal disease in which there is a progressive microarchitectural deterioration of bone tissue, generalized reduction in bone mineral density and this increases the person’s susceptibility to fractures. It is a polygenic condition in which many genes and environmental factors play key role. Bone morphogenetic protein-2 (BMP-2) plays a key role in osteoblast differentiation. In the present study, polymorphism c.893T>A, in BMP2 gene was assessed for its association with bone mineral density (BMD) variation in osteoporotic female population. Total 50 subjects were initially registered and on basis of BMD, 31 and 19 were diagnosed as osteoporotic and non-osteoporotic individuals, respectively. DNA was isolated from blood samples and 353 bp fragment having site of c.893T>A variation was amplified. RFLP was done using BsrI enzyme, to determine the genotype at locus c.893T>A. Osteoporotic group had the higher average age and more number of post-menopausal females. Nevertheless, none of the non-genetic factors that were investigated reached statistically significant association with BMD. Heterozygote genotype, AT, was the most prevalent genotype at this locus and variant homozygote, TT, was the least frequent. Females having variant genotype TT had 14.4% higher BMD than the subjects having wild type genotype, AA. However, genotype at this locus was not found tobe significantly associated with low BMD, thus it does not contribute to osteoporotic phenotype.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Characterization of human bone morphogenetic protein gene variants for possible roles in congenital heart disease

Congenital heart disease (CHD) is a complex illness with high rates of morbidity and mortality. In embryonic development, the heart is the first formed organ, which is strictly controlled by gene regulatory networks, including transcription factors, signaling pathways, epigenetic factors and microRNAs. Bone morphogenetic protein (BMP)-2 and -4 are essential in cardiogenesis as they can induce t...

متن کامل

Lack of effect of bone morphogenetic protein 2 and 4 gene polymorphisms on bone density in postmenopausal Turkish women.

We investigated the effect of bone morphogenetic protein 2 and 4 (BMP-2 and -4) gene polymorphisms on bone density in postmenopausal Turkish women with osteoporosis. The frequency of single-nucleotide polymorphisms (SNPs) of BMP-2 and -4 genes was analyzed in 101 osteoporotic-postmenopausal women and 52 postmenopausal women with positive bone mineral density scores. We evaluated the frequency o...

متن کامل

تاثیر لووتیروکسین با دوز جایگزینی روی تراکم استخوان در زنان قبل از یائسگی با هیپوتیروئیدی اولیه

Background and Objective: Patients with hypothyroidism require thyroid hormone replacement. Many studies have shown that bone density reduction is caused by suppressive doses of levothyroxine, but there are contradictory results regarding the effect of levothyroxine replacement dose (non suppressive). The purpose of this study was to investigate the effect of replacement doses of levothyroxine ...

متن کامل

بررسی ارتباط پلی مورفیسم Fok1 گیرنده ویتامین D3 با تراکم استخوان در زنان یائسه مبتلا به استئوپروز

Background and purpose: Osteoporosis is a multiple disease that is characterized by decrease in bone mass and bone strength. This decrease is more common in postmenopausal women due to decreased estrogen levels. Vitamin D3 plays a pivotal role in skeletal metabolism by binding to nuclear steroid receptors (receptors for vitamin D (VDR)). This study aimed at investigating the relationship betwee...

متن کامل

The effect of hormone therapy on bone mineral density and cardiovascular factors among Iranian female athletes with amenorrhea/oligomenorrhea: A randomized clinical trial

Background: Functional hypothalamic menstrual disorder (FHMD) has a destructive effect on the athlete’s bone mineral density and cardiovascular system. Utilizing hormone replacement therapy to treat FHMD in athletes is controversial. This study was conducted to examine the effect of hormone therapy on bone density and the cardiovascular system of professional female athletes with FHMD. ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014